1-6 of 6
Samir Parekh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma

Shashidhar S. Jatiani, Stephanie Christie, Violetta V. Leshchenko, Rinku Jain, Abhijeet Kapoor, Paola Bisignano, Clement Lee, H. Ümit Kaniskan, Donna Edwards, Fanye Meng, Alessandro Laganà, Youssef Youssef, Adrian Wiestner, Lapo Alinari, Jian Jin, Marta Filizola, Aneel K. Aggarwal, Samir Parekh
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (16): 4652–4663.
https://doi.org/10.1158/1078-0432.CCR-20-5039
Published: 15 August 2021
View article titled, SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma
Open the PDF for SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple Myeloma

William E. Pierceall, Michael D. Amatangelo, Nizar J. Bahlis, David S. Siegel, Adeeb Rahman, Oliver Van Oekelen, Paola Neri, Mary Young, Weiyuan Chung, Natalya Serbina, Samir Parekh, Amit Agarwal, Anjan Thakurta
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (22): 5895–5902.
https://doi.org/10.1158/1078-0432.CCR-20-1781
Published: 13 November 2020
View article titled, Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple Myeloma
Open the PDF for Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma

Deepak Perumal, Naoko Imai, Alessandro Laganà, John Finnigan, David Melnekoff, Violetta V. Leshchenko, Alexander Solovyov, Deepu Madduri, Ajai Chari, Hearn Jay Cho, Joel T. Dudley, Joshua D. Brody, Sundar Jagannath, Benjamin Greenbaum, Sacha Gnjatic, Nina Bhardwaj, Samir Parekh
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (2): 450–464.
https://doi.org/10.1158/1078-0432.CCR-19-2309
Published: 15 January 2020
View article titled, Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma
Open the PDF for Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Targeting HSF1: A Prime Integrator of Proteotoxic Stress Response in Myeloma

Samir Parekh
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (10): 2237–2238.
https://doi.org/10.1158/1078-0432.CCR-18-0030
Published: 14 May 2018
View article titled, Targeting HSF1: A Prime Integrator of Proteotoxic Stress Response in Myeloma
Open the PDF for Targeting HSF1: A Prime Integrator of Proteotoxic Stress Response in Myeloma in another window
Journal Articles

Integrative Genomic Analysis of Temozolomide Resistance in Diffuse Large B-Cell Lymphoma

Violetta V. Leshchenko, Pei-Yu Kuo, Zewei Jiang, Venu K. Thirukonda, Samir Parekh
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (2): 382–392.
https://doi.org/10.1158/1078-0432.CCR-13-0669
Published: 16 January 2014
View article titled, Integrative Genomic Analysis of Temozolomide Resistance in Diffuse Large B-Cell Lymphoma
Open the PDF for Integrative Genomic Analysis of Temozolomide Resistance in Diffuse Large B-Cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Akt Inhibitors MK-2206 and Nelfinavir Overcome mTOR Inhibitor Resistance in Diffuse Large B-cell Lymphoma

Adam M. Petrich, Violetta Leshchenko, Pei-Yu Kuo, Bing Xia, Venu K. Thirukonda, Netha Ulahannan, Shanisha Gordon, Melissa J. Fazzari, B. Hilda Ye, Joseph A. Sparano, Samir Parekh
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (9): 2534–2544.
https://doi.org/10.1158/1078-0432.CCR-11-1407
Published: 30 April 2012
View article titled, Akt Inhibitors MK-2206 and Nelfinavir Overcome mTOR Inhibitor Resistance in Diffuse Large B-cell Lymphoma
Open the PDF for Akt Inhibitors MK-2206 and Nelfinavir Overcome mTOR Inhibitor Resistance in Diffuse Large B-cell Lymphoma in another window
Includes: Supplementary data